(19)
(11) EP 2 542 584 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.12.2017 Bulletin 2017/50

(45) Mention of the grant of the patent:
25.10.2017 Bulletin 2017/43

(21) Application number: 11700115.6

(22) Date of filing: 07.01.2011
(51) International Patent Classification (IPC): 
C07K 16/26(2006.01)
A61P 35/00(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/EP2011/000049
(87) International publication number:
WO 2011/083091 (14.07.2011 Gazette 2011/28)

(54)

METHODS FOR TREATING PANCREATIC CANCER

VERFAHREN ZUR BEHANDLUNG VON BAUCHSPEICHELDRÜSENKREBS

MÉTHODES DE TRAITEMENT DU CANCER DU PANCRÉAS


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 08.01.2010 US 293612 P

(43) Date of publication of application:
09.01.2013 Bulletin 2013/02

(73) Proprietors:
  • Progastrine et Cancers S.à r.l.
    1450 Luxembourg (LU)
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    75654 Paris Cédex 13 (FR)
  • Centre National de la Recherche Scientifique (C.N.R.S.)
    75794 Paris Cedex 16 (FR)

(72) Inventors:
  • HOUHOU, Leïla
    34090 Montpellier (FR)
  • JOUBERT, Dominique
    34200 Sète (FR)
  • HOLLANDE, Frédéric
    34790 Grabels (FR)

(74) Representative: Regimbeau 
La Coupole Sud 379, rue Léon Blum
34000 Montpellier
34000 Montpellier (FR)


(56) References cited: : 
WO-A1-2006/032980
WO-A2-2008/063479
WO-A1-2008/076454
US-B1- 6 548 066
   
  • GOETZE J P ET AL: "Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.", CANCER 1 JUN 2000 LNKD- PUBMED:10861424, vol. 88, no. 11, 1 June 2000 (2000-06-01), pages 2487-2494, XP002625535, ISSN: 0008-543X
  • CAPLIN M ET AL: "Expression and processing of gastrin in pancreatic adenocarcinoma.", THE BRITISH JOURNAL OF SURGERY AUG 2000 LNKD- PUBMED:10931047, vol. 87, no. 8, August 2000 (2000-08), pages 1035-1040, XP002625536, ISSN: 0007-1323
  • MATTERS GAIL L ET AL: "Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression.", PANCREAS JUL 2009 LNKD- PUBMED:19465883, vol. 38, no. 5, July 2009 (2009-07), pages E151-E161, XP002625537, ISSN: 1536-4828
  • SMITH J P ET AL: "Identification of gastrin as a growth peptide in human pancreatic cancer.", THE AMERICAN JOURNAL OF PHYSIOLOGY JAN 1995 LNKD- PUBMED:7840313, vol. 268, no. 1 Pt 2, January 1995 (1995-01), pages R135-R141, XP9145263, ISSN: 0002-9513
  • SIDDHESHWAR R K ET AL: "Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma", GUT, BRITISH MEDICAL ASSOCIATION, LONDON, UK, vol. 48, no. 1, 1 January 2001 (2001-01-01), pages 47-52, XP002398546, ISSN: 0017-5749, DOI: DOI:10.1136/GUT.48.1.47
  • PETER C KONTUREK ET AL: "Effects of Cyclooxygenase-2 Inhibition on Serum and Tumor Gastrins and Expression of Apoptosis-Related Proteins in Colorectal Cancer", DIGESTIVE DISEASES AND SCIENCES, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 51, no. 4, 1 April 2006 (2006-04-01), pages 779-787, XP019277199, ISSN: 1573-2568
  • BARDRAM L: "PROGASTRIN IN SERUM FROM ZOLLINGER-ELLISON PATIENTS AN INDICATOR OF MALIGNANCY?", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 98, no. 6, 1 January 1990 (1990-01-01), pages 1420-1426, XP001053157, ISSN: 0016-5085
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).